Bradley E Chipps

Summary

Affiliation: Capital Allergy and Respiratory Disease Center
Country: USA

Publications

  1. doi request reprint Update in pediatric anaphylaxis: a systematic review
    Bradley E Chipps
    Capital Allergy and Respiratory Disease Center, Sacramento, CA 95819, USA
    Clin Pediatr (Phila) 52:451-61. 2013
  2. pmc Key findings and clinical implications from The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) study
    Bradley E Chipps
    Capital Allergy and Respiratory Disease Center, Sacramento, CA 95819, USA
    J Allergy Clin Immunol 130:332-42.e10. 2012
  3. doi request reprint Omalizumab: an update on efficacy and safety in moderate-to-severe allergic asthma
    Bradley E Chipps
    Capital Allergy and Respiratory Disease Center, Sacramento, CA 95819, USA
    Allergy Asthma Proc 33:377-85. 2012
  4. doi request reprint Management of acute bronchospasm in pediatric populations
    Bradley E Chipps
    Capital Allergy and Respiratory Disease Center, Sacramento, California 95819, USA
    Postgrad Med 118:39-43; discussion 43. 2005
  5. ncbi request reprint Inhaled corticosteroid therapy for patients with persistent asthma: learnings from studies of inhaled budesonide
    Bradley E Chipps
    Capital Allergy and Respiratory Disease Center, Sacramento, California 95819, USA
    Allergy Asthma Proc 30:217-28. 2009
  6. ncbi request reprint Asthma in infants and children
    Bradley E Chipps
    Capital Allergy and Respiratory Disease Center, Sacramento, California 95819, USA
    Clin Cornerstone 8:44-61. 2008
  7. doi request reprint Evaluation of infants and children with refractory lower respiratory tract symptoms
    Bradley E Chipps
    Capital Allergy and Respiratory Center, Sacramento, California 95819, USA
    Ann Allergy Asthma Immunol 104:279-83; quiz 283-5, 298. 2010
  8. ncbi request reprint Demographic and clinical characteristics of children and adolescents with severe or difficult-to-treat asthma
    Bradley E Chipps
    Capital Allergy and Respiratory Disease Center, Sacramento, CA 95819, USA
    J Allergy Clin Immunol 119:1156-63. 2007
  9. ncbi request reprint Targeted interventions for difficult-to-treat asthma
    Bradley E Chipps
    Capital Allergy and Respiratory Disease Center, Sacramento, CA 95819, USA
    Expert Opin Ther Targets 11:11-20. 2007
  10. ncbi request reprint What are the determinates of asthma control?
    Bradley E Chipps
    Capital Allergy and Respiratory Disease Center, Sacramento, California 95819, USA
    J Asthma 43:567-72. 2006

Detail Information

Publications21

  1. doi request reprint Update in pediatric anaphylaxis: a systematic review
    Bradley E Chipps
    Capital Allergy and Respiratory Disease Center, Sacramento, CA 95819, USA
    Clin Pediatr (Phila) 52:451-61. 2013
    ..Management of anaphylaxis in schools presents distinct challenges. Pediatricians are in a unique position to assess and treat these patients chronically...
  2. pmc Key findings and clinical implications from The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) study
    Bradley E Chipps
    Capital Allergy and Respiratory Disease Center, Sacramento, CA 95819, USA
    J Allergy Clin Immunol 130:332-42.e10. 2012
    ..IgE and allergen sensitization played a role in the majority of severe or difficult-to-treat asthmatic patients...
  3. doi request reprint Omalizumab: an update on efficacy and safety in moderate-to-severe allergic asthma
    Bradley E Chipps
    Capital Allergy and Respiratory Disease Center, Sacramento, CA 95819, USA
    Allergy Asthma Proc 33:377-85. 2012
    ....
  4. doi request reprint Management of acute bronchospasm in pediatric populations
    Bradley E Chipps
    Capital Allergy and Respiratory Disease Center, Sacramento, California 95819, USA
    Postgrad Med 118:39-43; discussion 43. 2005
    ..In addition, clinical data on the safety and efficacy of levalbuterol among pediatric patients are also presented...
  5. ncbi request reprint Inhaled corticosteroid therapy for patients with persistent asthma: learnings from studies of inhaled budesonide
    Bradley E Chipps
    Capital Allergy and Respiratory Disease Center, Sacramento, California 95819, USA
    Allergy Asthma Proc 30:217-28. 2009
    ....
  6. ncbi request reprint Asthma in infants and children
    Bradley E Chipps
    Capital Allergy and Respiratory Disease Center, Sacramento, California 95819, USA
    Clin Cornerstone 8:44-61. 2008
    ..Recent research efforts have focused on ways to improve inhalant drug delivery to the lungs and minimize oral and systemic bioavailability so as to improve the therapeutic benefit:risk ratio...
  7. doi request reprint Evaluation of infants and children with refractory lower respiratory tract symptoms
    Bradley E Chipps
    Capital Allergy and Respiratory Center, Sacramento, California 95819, USA
    Ann Allergy Asthma Immunol 104:279-83; quiz 283-5, 298. 2010
    ..To define the diagnostic possibilities for young children who present with recurrent wheeze...
  8. ncbi request reprint Demographic and clinical characteristics of children and adolescents with severe or difficult-to-treat asthma
    Bradley E Chipps
    Capital Allergy and Respiratory Disease Center, Sacramento, CA 95819, USA
    J Allergy Clin Immunol 119:1156-63. 2007
    ..Young patients with severe or difficult-to-treat asthma are an understudied population...
  9. ncbi request reprint Targeted interventions for difficult-to-treat asthma
    Bradley E Chipps
    Capital Allergy and Respiratory Disease Center, Sacramento, CA 95819, USA
    Expert Opin Ther Targets 11:11-20. 2007
    ..Newer and developing therapies that cater to specific types of asthmatic patients and may lead to improved outcomes in those patients for whom standard care is insufficient are also looked at...
  10. ncbi request reprint What are the determinates of asthma control?
    Bradley E Chipps
    Capital Allergy and Respiratory Disease Center, Sacramento, California 95819, USA
    J Asthma 43:567-72. 2006
    ....
  11. doi request reprint Longitudinal validation of the Test for Respiratory and Asthma Control in Kids in pediatric practices
    Bradley Chipps
    Capital Allergy and Respiratory Disease Center, 5609 J St, Suite C, Sacramento, CA 95819, USA
    Pediatrics 127:e737-47. 2011
    ..This longitudinal study in children treated by pediatricians evaluated the responsiveness of TRACK to changes in respiratory- and asthma-control status over time and further assessed TRACK's reliability and validity...
  12. ncbi request reprint Variability in asthma severity in pediatric subjects with asthma previously receiving short-acting beta2-agonists
    Bradley E Chipps
    Capital Allergy and Respiratory Disease Center, Sacramento, California 95819, and University of Wisconsin, Madison, Wisconsin, USA
    J Pediatr 148:517-21. 2006
    ..At baseline, all subjects met National Asthma Education and Prevention Program criteria for moderate/severe asthma...
  13. ncbi request reprint Assessment and treatment of acute asthma in children
    Bradley E Chipps
    Capital Allergy and Respiratory Disease Center, Sacramento, California, USA
    J Pediatr 147:288-94. 2005
  14. doi request reprint Antihistamine treatment for allergic rhinitis: different routes, different outcomes?
    Bradley E Chipps
    Capital Allergy and Respiratory Disease Center, Sacramento, California, USA
    Allergy Asthma Proc 30:589-94. 2009
    ..Both oral and intranasal antihistamines are safe and well tolerated and meet the needs of patients with allergic rhinitis, especially those with mild to moderate disease...
  15. ncbi request reprint Budesonide inhalation suspension reduces the need for emergency intervention in pediatric asthma: a named-patient case series
    Bradley E Chipps
    Capital Allergy and Respiratory Disease Center, Sacramento, California 95819, USA
    J Asthma 40:895-900. 2003
    ..In this case series, budesonide inhalation suspension represents a safe, effective treatment option to prevent recurrent emergency intervention for patients < 3 years of age with poorly controlled asthma...
  16. ncbi request reprint Determinants of asthma and its clinical course
    Bradley E Chipps
    Capitol Allergy and Respiratory Disease Center, Sacramento, California, USA
    Ann Allergy Asthma Immunol 93:309-15; quiz 315-8, 380. 2004
    ....
  17. ncbi request reprint Dose counting and the use of pressurized metered-dose inhalers: running on empty
    Nancy Sander
    Allergy and Asthma Network Mothers of Asthmatics, Fairfax, Virginia, USA
    Ann Allergy Asthma Immunol 97:34-8. 2006
    ..The pMDI is an economic and portable medication delivery system, but the device does not indicate how much medicine remains in the canister once a patient starts using it...
  18. ncbi request reprint Gender differences in IgE-mediated allergic asthma in the epidemiology and natural history of asthma: Outcomes and Treatment Regimens (TENOR) study
    June H Lee
    Genentech, Inc, South San Francisco, California 94080, USA
    J Asthma 43:179-84. 2006
    ....
  19. ncbi request reprint Office-based objective measures in childhood asthma
    Joseph D Spahn
    National Jewish Medical and Research Center, Denver, Colorado, USA
    J Pediatr 148:11-5. 2006
  20. ncbi request reprint Risk factors associated with persistent airflow limitation in severe or difficult-to-treat asthma: insights from the TENOR study
    June H Lee
    Genentech, Inc, 1 DNA Way, MS 453B, South San Francisco, CA 94080, USA
    Chest 132:1882-9. 2007
    ..A better understanding is needed regarding factors associated with persistent airway obstruction; this study was performed to determine demographic and clinical characteristics associated with persistent airflow limitation...